These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 28530660)

  • 1. Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling.
    Jin Y; Muhl L; Burmakin M; Wang Y; Duchez AC; Betsholtz C; Arthur HM; Jakobsson L
    Nat Cell Biol; 2017 Jun; 19(6):639-652. PubMed ID: 28530660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
    Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
    Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.
    Garrido-Martin EM; Nguyen HL; Cunningham TA; Choe SW; Jiang Z; Arthur HM; Lee YJ; Oh SP
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2232-6. PubMed ID: 25082229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling.
    Tual-Chalot S; Garcia-Collado M; Redgrave RE; Singh E; Davison B; Park C; Lin H; Luli S; Jin Y; Wang Y; Lawrie A; Jakobsson L; Arthur HM
    Circ Res; 2020 Jan; 126(2):243-257. PubMed ID: 31805812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia.
    Gallardo-Vara E; Tual-Chalot S; Botella LM; Arthur HM; Bernabeu C
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30108051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoglin deficiency impairs VEGFR2 but not FGFR1 or TIE2 activation and alters VEGF-mediated cellular responses in human primary endothelial cells.
    Zhang Q; Wang C; Cannavicci A; Faughnan ME; Kutryk MJB
    Transl Res; 2021 Sep; 235():129-143. PubMed ID: 33894400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia.
    Choi EJ; Chen W; Jun K; Arthur HM; Young WL; Su H
    PLoS One; 2014; 9(2):e88511. PubMed ID: 24520391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietin-2 Inhibition Rescues Arteriovenous Malformation in a Smad4 Hereditary Hemorrhagic Telangiectasia Mouse Model.
    Crist AM; Zhou X; Garai J; Lee AR; Thoele J; Ullmer C; Klein C; Zabaleta J; Meadows SM
    Circulation; 2019 Apr; 139(17):2049-2063. PubMed ID: 30744395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell biology of Endoglin in hereditary hemorrhagic telangiectasia.
    Sugden WW; Siekmann AF
    Curr Opin Hematol; 2018 May; 25(3):237-244. PubMed ID: 29438260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia.
    Crist AM; Lee AR; Patel NR; Westhoff DE; Meadows SM
    Angiogenesis; 2018 May; 21(2):363-380. PubMed ID: 29460088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain.
    Xu B; Wu YQ; Huey M; Arthur HM; Marchuk DA; Hashimoto T; Young WL; Yang GY
    J Cereb Blood Flow Metab; 2004 Feb; 24(2):237-44. PubMed ID: 14747750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of arteriovenous malformations in the absence of endoglin.
    Mahmoud M; Allinson KR; Zhai Z; Oakenfull R; Ghandi P; Adams RH; Fruttiger M; Arthur HM
    Circ Res; 2010 Apr; 106(8):1425-33. PubMed ID: 20224041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
    Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
    Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial endoglin does not protect against arteriovenous malformations.
    Singh E; Redgrave RE; Phillips HM; Arthur HM
    Angiogenesis; 2020 Nov; 23(4):559-566. PubMed ID: 32506200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective Flow-Migration Coupling Causes Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
    Park H; Furtado J; Poulet M; Chung M; Yun S; Lee S; Sessa WC; Franco CA; Schwartz MA; Eichmann A
    Circulation; 2021 Sep; 144(10):805-822. PubMed ID: 34182767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
    Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions.
    Snodgrass RO; Chico TJA; Arthur HM
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting.
    Sharma S; Ehrlich M; Zhang M; Blobe GC; Henis YI
    Commun Biol; 2024 Jan; 7(1):112. PubMed ID: 38242992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
    Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P
    J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMAD4 Prevents Flow Induced Arteriovenous Malformations by Inhibiting Casein Kinase 2.
    Ola R; Künzel SH; Zhang F; Genet G; Chakraborty R; Pibouin-Fragner L; Martin K; Sessa W; Dubrac A; Eichmann A
    Circulation; 2018 Nov; 138(21):2379-2394. PubMed ID: 29976569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.